IKT inhibikase.com Company Profit

Official company branding of inhibikase.com (IKT)

Inhibikase Therapeutics (IKT) specializes in developing medical solutions to combat nervous system pathologies. This price chart illustrates profit dynamics, which currently stand at -0.06. The brand has earned recognition for seeking ways to completely eliminate the causes of neurodegeneration. Currently, Inhibikase Therapeutics (IKT) is focusing on successfully completing clinical trials to eventually establish partnerships with the largest pharmaceutical behemoths.

IKT (Inhibikase Therapeutics) Net Profit history from 07/04/2022 to 11/01/2026

Financial and market metric breakdowns for Inhibikase Therapeutics, Inc. (IKT)

- current quotes and average value forecast:
Market Chart Inhibikase Pharma|IKT - Price Target Chart
- market capitalization data:
Market Capitalization Inhibikase Pharma|IKT - Enterprise Value
- book capitalization information:
Accounting Value of a Share Inhibikase Therapeutics|IKT - Book Capitalization|Market Capitalization to Book Value inhibikase.com|IKT - Company Total Assets
- debt burden and liquidity indicators:
Debt to Equity Inhibikase Therapeutics|IKT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Inhibikase Therapeutics Inc|IKT - Company Debts|Debts to Book Capitalization Inhibikase Pharma|IKT - Company Long-Term Debts|Company Short-Term Debts Inhibikase Therapeutics|Interim Coverage Ratio inhibikase.com
- net income and valuation multiples indicators:
IKT - Net Profit
Basic company analysis:Inhibikase Therapeutics
Finished products of Inhibikase

This indicator serves as a key filter for the issuer's investment reliability. The metric measures net profit per unit of equity, reflecting the actual efficiency of resource utilization. By analyzing the company's profit margins, an investor can observe the dynamics of the business's fundamental health in real time. For Inhibikase Therapeutics (IKT), this chart captures a critical reduction in capital. Constant R&D expenditures in the absence of sales render the current trajectory loss-making.

Direct competitors

BIIB - Net Financial Result|Company Net Income Neurocrine Biosciences|Company Profit RGC (regencellbioscience.com)|Net Profit AXSM|ACAD (ACADIA Pharma) - Final Profit|Net Profit XENE (Xenon Pharmaceuticals Inc)|Net Financial Result Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Net Profit|CPRX: Company Net Income|DNLI: Net Profit|HRMY - Net Financial Result|Company Net Income Biohaven Pharmaceutical|Net Profit Amylyx Corp|Net Profit TRVI|Net Profit praxismedicines.com (PRAX)|Company Net Income Anavex Life Sciences Corp. AVXL|Net Financial Result CeriBell Inc (CBLL)|Prothena Biosciences - Net Profit|Company Net Income Alector, Inc.|ANNX (Annexon, Inc.) - Net Income|Omeros - Final Profit|Net Income NGNE|ACIU (AC Immune S.A.) - Profit After Payment of Taxes|Net Profit VYGR|NMRA (Neumora Corp) - Final Profit|Net Profit SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Company Net Income|ACOG - Company Net Income|Final Profit CGTX (cogrx.com)|SAVA: Net Profit|Assertio (ASRT) - Net Profit|Company Net Income Coya Therapeutics Inc|VistaGen Therapeutics Inc - Profit After Tax|Net Profit OVID|ABOS - Company Net Income|CervoMed Inc - Net Income|Net Profit Alterity Therapeutics Ltd. ATHE|CLNN: Net Income|PepGen Inc. - Profit After Payment of Taxes|JUNS: Net Profit|RLMD - Net Financial Result|ANVS (Annovis Bio Corp) - Net Profit|Net Income Grace Tx (GRCE)|Company Net Income Firefly Neuroscience, Inc (AIFF)|Net Financial Result anewmeds.com|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|Net Financial Result Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Company Net Income|NRXS - Net Profit|HSDT (heliusmedical.com) - Net Income|PASG: Profit After Payment of Taxes|Company Net Income Neuphoria Therapeutics, Inc.|Company Profit NERV (Minerva Neurosciences Inc)|Net Profit ATHA|ADXN - Company Net Income|Alzamend Neuro - Net Income|Net Profit Cyclerion Therapeutics Inc. CYCN|PTIX - Company Net Income|Final Profit KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Company Net Income|Company Net Income Avenue Therapeutics Inc (ATXI)|BCLI (Brainstorm Cell) - Net Profit|caratherapeutics.com (CARA) - Net Financial Result|Company Net Income Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Company Profit|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|Final Profit LBPH|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NRBO: Net Profit|SAGE (Sage Therapeutics Inc.) - Company Net Income|SNPX (Neurotrope) - Net Profit|Trevena Inc (TRVN) - Net Financial Result|Company Net Income Vigil Neuroscience (VIGL)|Net Profit Anew Medical Inc. (WENA)|Net Profit CERE (Cerevel Therapeutics, Inc.)